APO Research
Talk to an analyst

APO RESEARCH · REPORT

POC HbA1C Testing

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

In this report, we mainly study the devices for POC HbA1C Testing without services.

Selected research

Market Outlook & Growth Opportunities

Global POC HbA1C Testing Market Outlook and Growth Opportunities 2026

20 December 2025198 pages

Choose your research edition.

Industry ResearchPOC HbA1C Testing Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal POC HbA1C Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal POC HbA1C Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal POC HbA1C Testing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal POC HbA1C Testing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.

HbA1c is your average blood glucose (sugar) levels for the last two to three months.

The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.

Read the full market overview

In this report, we mainly study the devices for POC HbA1C Testing without services.

The major players in global POC HbA1C Testing market include Abbott, Siemens, Roche, etc. The top 3 players occupy about 80% shares of the global market. North America and Europe are main markets, they occupy about 75% of the global market. Immunoassay is the main type, with a share about 50%. Hospital & Clinics is the main application, which holds a share about 60%.

This report provides an overview of the global POC HbA1C Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of POC HbA1C Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents POC HbA1C Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global POC HbA1C Testing market.

POC HbA1C Testing Segment by Company

Abbott

Siemens

Roche

Bio-Rad

GREEN CROSS MEDIS

Trinity Biotech

HUMAN Diagnostics

Sinocare (PTS Diagnostics)

Erba Diagnostics

EKF Diagnostics

OSANG Healthcare

SD Biosensor

POC HbA1C Testing Segment by Type

Immunoassay

Boronate Affinity

Others

POC HbA1C Testing Segment by Application

Hospital and Clinics

Diagnostic Laboratories

Others

POC HbA1C Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global POC HbA1C Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the POC HbA1C Testing key companies, revenue, market share, and recent developments.

3. To split the POC HbA1C Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions POC HbA1C Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify POC HbA1C Testing significant trends, drivers, influence factors in global and regions.

6. To analyze POC HbA1C Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global POC HbA1C Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of POC HbA1C Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of POC HbA1C Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global POC HbA1C Testing industry.

Chapter 3: Detailed analysis of POC HbA1C Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of POC HbA1C Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of POC HbA1C Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. POC HbA1C Testing Industry Trends Table 2. POC HbA1C Testing Industry Drivers Table 3. POC HbA1C Testing Industry Opportunities and Challenges Table 4. POC HbA1C Testing Industry Restraints Table 5. Global POC HbA1C Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global POC HbA1C Testing Revenue Share by Company (2021-2026) Table 7. Global POC HbA1C Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global POC HbA1C Testing Key Company Manufacturing Base & Headquarters Table 9. Global POC HbA1C Testing Company, Product Type & Application Table 10. Global POC HbA1C Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global POC HbA1C Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Immunoassay Table 15. Significant Companies of Boronate Affinity Table 16. Significant Companies of Others Table 17. Global POC HbA1C Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global POC HbA1C Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global POC HbA1C Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global POC HbA1C Testing Sales Value Share by Type (2021-2026) Table 21. Global POC HbA1C Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital and Clinics Table 23. Significant Companies of Diagnostic Laboratories Table 24. Significant Companies of Others Table 25. Global POC HbA1C Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global POC HbA1C Testing Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global POC HbA1C Testing Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global POC HbA1C Testing Sales Value Share by Application (2021-2026) Table 29. Global POC HbA1C Testing Sales Value Share by Application (2027-2032) Table 30. Global POC HbA1C Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global POC HbA1C Testing Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global POC HbA1C Testing Sales Value Share by Region (2021-2026) Table 33. Global POC HbA1C Testing Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global POC HbA1C Testing Sales Value Share by Region (2027-2032) Table 35. Global POC HbA1C Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global POC HbA1C Testing Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global POC HbA1C Testing Sales Value Market Share by Country (2021-2026) Table 38. Global POC HbA1C Testing Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global POC HbA1C Testing Sales Value Market Share by Country (2027-2032) Table 40. Abbott Company Information Table 41. Abbott Business Overview Table 42. Abbott POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Abbott POC HbA1C Testing Product Portfolio Table 44. Abbott Recent Development Table 45. Siemens Company Information Table 46. Siemens Business Overview Table 47. Siemens POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Siemens POC HbA1C Testing Product Portfolio Table 49. Siemens Recent Development Table 50. Roche Company Information Table 51. Roche Business Overview Table 52. Roche POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Roche POC HbA1C Testing Product Portfolio Table 54. Roche Recent Development Table 55. Bio-Rad Company Information Table 56. Bio-Rad Business Overview Table 57. Bio-Rad POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bio-Rad POC HbA1C Testing Product Portfolio Table 59. Bio-Rad Recent Development Table 60. GREEN CROSS MEDIS Company Information Table 61. GREEN CROSS MEDIS Business Overview Table 62. GREEN CROSS MEDIS POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. GREEN CROSS MEDIS POC HbA1C Testing Product Portfolio Table 64. GREEN CROSS MEDIS Recent Development Table 65. Trinity Biotech Company Information Table 66. Trinity Biotech Business Overview Table 67. Trinity Biotech POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Trinity Biotech POC HbA1C Testing Product Portfolio Table 69. Trinity Biotech Recent Development Table 70. HUMAN Diagnostics Company Information Table 71. HUMAN Diagnostics Business Overview Table 72. HUMAN Diagnostics POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. HUMAN Diagnostics POC HbA1C Testing Product Portfolio Table 74. HUMAN Diagnostics Recent Development Table 75. Sinocare (PTS Diagnostics) Company Information Table 76. Sinocare (PTS Diagnostics) Business Overview Table 77. Sinocare (PTS Diagnostics) POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sinocare (PTS Diagnostics) POC HbA1C Testing Product Portfolio Table 79. Sinocare (PTS Diagnostics) Recent Development Table 80. Erba Diagnostics Company Information Table 81. Erba Diagnostics Business Overview Table 82. Erba Diagnostics POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Erba Diagnostics POC HbA1C Testing Product Portfolio Table 84. Erba Diagnostics Recent Development Table 85. EKF Diagnostics Company Information Table 86. EKF Diagnostics Business Overview Table 87. EKF Diagnostics POC HbA1C Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. EKF Diagnostics POC HbA1C Testing Product Portfolio Table 89. EKF Diagnostics Recent Development Table 90. OSANG Healthcare Company Information Table 91. OSANG Healthcare Business Overview Table 92. OSANG Healthcare POC HbA1C Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. OSANG Healthcare POC HbA1C Testing Product Portfolio Table 94. OSANG Healthcare Recent Development Table 95. SD Biosensor Company Information Table 96. SD Biosensor Business Overview Table 97. SD Biosensor POC HbA1C Testing Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. SD Biosensor POC HbA1C Testing Product Portfolio Table 99. SD Biosensor Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. POC HbA1C Testing Product Image Figure 2. Global POC HbA1C Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global POC HbA1C Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global POC HbA1C Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Immunoassay Image Figure 8. Boronate Affinity Image Figure 9. Others Image Figure 10. Global POC HbA1C Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global POC HbA1C Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global POC HbA1C Testing Sales Value Share by Type (2021-2032) Figure 13. Hospital and Clinics Image Figure 14. Diagnostic Laboratories Image Figure 15. Others Image Figure 16. Global POC HbA1C Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global POC HbA1C Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global POC HbA1C Testing Sales Value Share by Application (2021-2032) Figure 19. Global POC HbA1C Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global POC HbA1C Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America POC HbA1C Testing Sales Value (2021-2032) & (US$ Million) Figure 22. North America POC HbA1C Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe POC HbA1C Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Europe POC HbA1C Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific POC HbA1C Testing Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific POC HbA1C Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America POC HbA1C Testing Sales Value (2021-2032) & (US$ Million) Figure 28. South America POC HbA1C Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa POC HbA1C Testing Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa POC HbA1C Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt POC HbA1C Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Immunoassay
  • Boronate Affinity
  • Others
Applications
  • Hospital and Clinics
  • Diagnostic Laboratories
  • Others
Companies covered
  • Abbott
  • Siemens
  • Roche
  • Bio-Rad
  • GREEN CROSS MEDIS
  • Trinity Biotech
  • HUMAN Diagnostics
  • Sinocare (PTS Diagnostics)
  • Erba Diagnostics
  • EKF Diagnostics
  • OSANG Healthcare
  • SD Biosensor

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global POC HbA1C Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global POC HbA1C Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 POC HbA1C Testing Market Dynamics
  1. 2.1 POC HbA1C Testing Industry Trends
  2. 2.2 POC HbA1C Testing Industry Drivers
  3. 2.3 POC HbA1C Testing Industry Opportunities and Challenges
  4. 2.4 POC HbA1C Testing Industry Restraints
3 POC HbA1C Testing Market by Company
  1. 3.1 Global POC HbA1C Testing Company Revenue Ranking in 2025
  2. 3.2 Global POC HbA1C Testing Revenue by Company (2021-2026)
  3. 3.3 Global POC HbA1C Testing Company Ranking (2024-2026)
  4. 3.4 Global POC HbA1C Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global POC HbA1C Testing Company Product Type and Application
  6. 3.6 Global POC HbA1C Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global POC HbA1C Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 POC HbA1C Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 POC HbA1C Testing Market by Type
  1. 4.1 POC HbA1C Testing Type Introduction
  2. 4.1.1 Immunoassay
  3. 4.1.2 Boronate Affinity
  4. 4.1.3 Others
  5. 4.2 Global POC HbA1C Testing Sales Value by Type
  6. 4.2.1 Global POC HbA1C Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global POC HbA1C Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global POC HbA1C Testing Sales Value Share by Type (2021-2032)
5 POC HbA1C Testing Market by Application
  1. 5.1 POC HbA1C Testing Application Introduction
  2. 5.1.1 Hospital and Clinics
  3. 5.1.2 Diagnostic Laboratories
  4. 5.1.3 Others
  5. 5.2 Global POC HbA1C Testing Sales Value by Application
  6. 5.2.1 Global POC HbA1C Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global POC HbA1C Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global POC HbA1C Testing Sales Value Share by Application (2021-2032)
6 POC HbA1C Testing Regional Value Analysis
  1. 6.1 Global POC HbA1C Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global POC HbA1C Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global POC HbA1C Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global POC HbA1C Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America POC HbA1C Testing Sales Value (2021-2032)
  7. 6.3.2 North America POC HbA1C Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe POC HbA1C Testing Sales Value (2021-2032)
  10. 6.4.2 Europe POC HbA1C Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific POC HbA1C Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific POC HbA1C Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America POC HbA1C Testing Sales Value (2021-2032)
  16. 6.6.2 South America POC HbA1C Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa POC HbA1C Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa POC HbA1C Testing Sales Value Share by Country, 2025 VS 2032
7 POC HbA1C Testing Country-level Value Analysis
  1. 7.1 Global POC HbA1C Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global POC HbA1C Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global POC HbA1C Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global POC HbA1C Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt POC HbA1C Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt POC HbA1C Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt POC HbA1C Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott POC HbA1C Testing Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Siemens
  8. 8.2.1 Siemens Company Information
  9. 8.2.2 Siemens Business Overview
  10. 8.2.3 Siemens POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Siemens POC HbA1C Testing Product Portfolio
  12. 8.2.5 Siemens Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche POC HbA1C Testing Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Bio-Rad
  20. 8.4.1 Bio-Rad Company Information
  21. 8.4.2 Bio-Rad Business Overview
  22. 8.4.3 Bio-Rad POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Rad POC HbA1C Testing Product Portfolio
  24. 8.4.5 Bio-Rad Recent Developments
  25. 8.5 GREEN CROSS MEDIS
  26. 8.5.1 GREEN CROSS MEDIS Company Information
  27. 8.5.2 GREEN CROSS MEDIS Business Overview
  28. 8.5.3 GREEN CROSS MEDIS POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GREEN CROSS MEDIS POC HbA1C Testing Product Portfolio
  30. 8.5.5 GREEN CROSS MEDIS Recent Developments
  31. 8.6 Trinity Biotech
  32. 8.6.1 Trinity Biotech Company Information
  33. 8.6.2 Trinity Biotech Business Overview
  34. 8.6.3 Trinity Biotech POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Trinity Biotech POC HbA1C Testing Product Portfolio
  36. 8.6.5 Trinity Biotech Recent Developments
  37. 8.7 HUMAN Diagnostics
  38. 8.7.1 HUMAN Diagnostics Company Information
  39. 8.7.2 HUMAN Diagnostics Business Overview
  40. 8.7.3 HUMAN Diagnostics POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 HUMAN Diagnostics POC HbA1C Testing Product Portfolio
  42. 8.7.5 HUMAN Diagnostics Recent Developments
  43. 8.8 Sinocare (PTS Diagnostics)
  44. 8.8.1 Sinocare (PTS Diagnostics) Company Information
  45. 8.8.2 Sinocare (PTS Diagnostics) Business Overview
  46. 8.8.3 Sinocare (PTS Diagnostics) POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sinocare (PTS Diagnostics) POC HbA1C Testing Product Portfolio
  48. 8.8.5 Sinocare (PTS Diagnostics) Recent Developments
  49. 8.9 Erba Diagnostics
  50. 8.9.1 Erba Diagnostics Company Information
  51. 8.9.2 Erba Diagnostics Business Overview
  52. 8.9.3 Erba Diagnostics POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Erba Diagnostics POC HbA1C Testing Product Portfolio
  54. 8.9.5 Erba Diagnostics Recent Developments
  55. 8.10 EKF Diagnostics
  56. 8.10.1 EKF Diagnostics Company Information
  57. 8.10.2 EKF Diagnostics Business Overview
  58. 8.10.3 EKF Diagnostics POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EKF Diagnostics POC HbA1C Testing Product Portfolio
  60. 8.10.5 EKF Diagnostics Recent Developments
  61. 8.11 OSANG Healthcare
  62. 8.11.1 OSANG Healthcare Company Information
  63. 8.11.2 OSANG Healthcare Business Overview
  64. 8.11.3 OSANG Healthcare POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 OSANG Healthcare POC HbA1C Testing Product Portfolio
  66. 8.11.5 OSANG Healthcare Recent Developments
  67. 8.12 SD Biosensor
  68. 8.12.1 SD Biosensor Company Information
  69. 8.12.2 SD Biosensor Business Overview
  70. 8.12.3 SD Biosensor POC HbA1C Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SD Biosensor POC HbA1C Testing Product Portfolio
  72. 8.12.5 SD Biosensor Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst